Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis
Stanley Cohen(Metroplex Clinical Research Center), Viatcheslav R. Akmaev, Susan Dina Ghiassian(Boston Engineering (United States)), Johanna B. Withers(BG Medicine (United States)), Theodore Mellors(BG Medicine (United States)), Jeffrey R. Curtis, Lixia Zhang(BG Medicine (United States)), Alex Jones(BG Medicine (United States))
Cited by 1
Related Papers
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
A Proteome-Scale Map of the Human Interactome Network
|Cell|2014|1.5k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis Care & Research|2015|1.1k